Potential role of poly(adenosine 5′-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock

被引:109
|
作者
Soriano, FG [1 ]
Nogueira, AC
Caldini, EG
Lins, MH
Teixeira, AC
Cappi, SB
Lotufo, PA
Bernik, MMS
Zsengellér, Z
Chen, M
Szabó, C
机构
[1] Univ Sao Paulo, Univ Hosp, Disciplina Emergencias Clin, BR-05508 Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Med, Dept Anat Patol, BR-05508 Sao Paulo, Brazil
[3] Inotek Pharmaceut Corp, Beverly, MA USA
[4] Semmelweis Univ, Sch Med, Dept Human Physiol & Expt Res, Budapest, Hungary
关键词
sepsis; poly(ADP-ribose) polymerase; peroxynitrite; heart dysfunction; oxidative and nitrosative stress;
D O I
10.1097/01.CCM.0000206470.47721.8D
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. Sepsis is associated with increased production of superoxide and nitric oxide, with consequent peroxynitrite generation. Cardiodepression is induced in the heart during oxidative stress associated with septic shock. Oxidative and nitrosative stress can lead to activation of the nuclear enzyme poly(adenosine 5'-diphosphate [ADP]-ribose) polymerase (PARP), with subsequent loss of myocardial contractile function. The aim of the study was to investigate whether cardiodepression found in septic patients is associated with plasma markers of myocardial necrosis and with myocardial PARP activation. Design: Prospective and observational study. Setting. University hospital intensive care unit for clinical and surgical patients. Patients: Twenty-five patients older than 18 yrs presenting with severe sepsis or septic shock. Patients with history of chronic heart failure, cancer, coronary artery disease, diabetes, or acquired immune deficiency syndrome were excluded. Interventions. Patients were followed for 28 days, and biochemical and hemodynamic data were collected on days 1, 3, and 6 of sepsis. The groups were survivors and nonsurvivors, defined only after the end of clinical patient evolution. Heart sections from patients who died were analyzed with hematoxylin-eosin and Picro Sirius-Red immunostaining and with electron microscopy. Measurements and Main Results. The study population included 25 individuals, of whom 12 (48%) died during the 6 days of follow-up. The initial data of the inflammation marker C-reactive protein and Acute Physiologic and Chronic Health. Evaluation severity were similar in both groups (nonsurvivors, 26 +/- 2; survivors, 24 +/- 5). Overall, an increase in plasma troponin level was related to increased mortality risk. In patients who died, significant myocardial damage was detected, and histologic analysis of heart sections showed inflammatory infiltration, increased collagen deposition, and derangement of mitochondrial cristae. Immunohistochemical staining for poly(ADP-ribose) (PAR), the product of activated PARP, was demonstrated in septic hearts. There was a positive correlation between PAR staining densitometry and troponin I (r(2) = 0.73; p < .05), and the correlation of PAR staining densitometry and left ventricular systolic stroke work index was r(2) = 0.33 (p = .0509). Conclusion: There is significant PARP activation in the hearts of septic patients with impaired cardiac function. We hypothesize that PARP activation may be partly responsible for the cardiac depression seen in humans with severe sepsis.
引用
收藏
页码:1073 / 1079
页数:7
相关论文
共 43 条
  • [1] Potential role of poly(ADP-ribose) activation in myocardial contractile dysfunction of human septic shock
    AC Nogueira
    M Lins
    W Hoshino
    L Gonzaga
    V Kawabata
    J Barradas
    S Cappi
    A Duarte
    P Bisele
    F Maia
    M Miranda
    M Bernik
    PA Lotufo
    FG Soriano
    Critical Care, 11 (Suppl 3):
  • [2] Is it poly(adenosine 5′-diphosphate-ribose) polymerase or hypothermia?
    Marion, DW
    CRITICAL CARE MEDICINE, 2002, 30 (11) : 2595 - 2596
  • [3] HUMAN AUTOANTIBODIES TO POLY(ADENOSINE DIPHOSPHATE-RIBOSE) POLYMERASE
    YAMANAKA, H
    WILLIS, EH
    PENNING, CA
    PEEBLES, CL
    TAN, EM
    CARSON, DA
    JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (03): : 900 - 904
  • [4] Mesenteric injury after cardiopulmonary bypass:: Role of poly(adenosine 5'-diphosphate-ribose) polymerase
    Szabó, G
    Soós, M
    Mandera, S
    Heger, U
    Flechtenmacher, C
    Seres, L
    Zsengellér, Z
    Sack, FU
    Szabó, C
    Hagl, S
    CRITICAL CARE MEDICINE, 2004, 32 (12) : 2392 - 2397
  • [5] Poly(adenosine diphosphate-ribose) polymerase expression in human traumatic brain injury
    Ang, BT
    Yap, E
    Lim, J
    Tan, WL
    Ng, PY
    Ng, I
    Yeo, TT
    JOURNAL OF NEUROSURGERY, 2003, 99 (01) : 125 - 130
  • [6] Poly Adenosine Diphosphate-Ribose Polymerase Inhibitors and Heat Shock Protein 90 Inhibitors
    Riely, Gregory J.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : S1803 - S1804
  • [7] Activation of poly(adenosine diphosphate-ribose) polymerase in mouse tumors treated by photodynamic therapy
    Korbelik, M
    Sun, JH
    Payne, PW
    PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2003, 78 (04) : 400 - 406
  • [8] Poly-adenosine diphosphate-ribose polymerase inhibition for myocardial protection: Pathophysiologic and physiologic considerations
    Bloch, W
    Mehlhorn, U
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 128 (02): : 323 - 324
  • [9] Poly(adenosine 5′-diphosphate) ribose polymerase activation as a cause of metabolic dysfunction in critical illness
    Liaudet, L
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2002, 5 (02): : 175 - 184
  • [10] The role of poly (adenosine 5′-diphosphate-ribose) polymerase in the response of pituitary tumor cells to reactive oxygen species
    Newton, CJ
    Bilko, D
    Tichomirowa, M
    Renner, U
    Stalla, GK
    ENDOCRINOLOGY, 2005, 146 (03) : 1119 - 1127